[Impact of combined oral contraceptives and spironolactone on hirsutism and quality of life].

Author: BegonEmmanuelle, BernardValérie, GrouthierVirginie, HockeClaude, LefoulonNina, Perrissin-FabertMarie

Paper Details 
Original Abstract of the Article :
Combined oral contraceptives (COC) and spironolactone are the first and second-line treatments of mild hirsutism, since the use of cyproterone acetate was restricted to the treatment of severe hirsutism by the French guidelines for hyperandrogenism published in May 2020. Because spironolactone was u...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.gofs.2022.06.001

データ提供:米国国立医学図書館(NLM)

Evaluating the Efficacy of Combined Oral Contraceptives and Spironolactone for Mild Hirsutism

This study delves into the realm of hormonal imbalances, specifically focusing on the treatment of mild hirsutism in non-menopausal women. The authors investigate the efficacy of two commonly used treatments: combined oral contraceptives (COC) and spironolactone. The research aims to provide valuable insights into the effectiveness of these therapies, addressing a critical need for a deeper understanding of their impact on hirsutism and quality of life.

Evaluating Treatment Efficacy in the Desert of Hirsutism

This research explores the impact of COC and spironolactone on mild hirsutism, providing a practical guide for physicians navigating the complexities of hormonal imbalances. The study highlights the importance of assessing both the clinical efficacy and the impact on quality of life, recognizing that successful treatment involves more than just symptom reduction.

Navigating the Desert of Hormonal Imbalances

This study offers valuable insights into the treatment options for mild hirsutism in non-menopausal women. The authors provide a roadmap for physicians to navigate the complex terrain of hormonal imbalances, helping them tailor treatments that effectively manage symptoms and improve quality of life. It's like navigating a desert - understanding the landscape and its challenges is crucial for achieving a successful journey.

Dr.Camel's Conclusion

The authors provide a valuable guide for physicians and patients navigating the desert of hirsutism, offering insights into the efficacy and impact of COC and spironolactone treatments. It highlights the importance of tailoring treatment strategies to individual needs and considering not only clinical outcomes but also quality of life.

Date :
  1. Date Completed 2022-09-08
  2. Date Revised 2022-10-24
Further Info :

Pubmed ID

35697273

DOI: Digital Object Identifier

10.1016/j.gofs.2022.06.001

Related Literature

SNS
PICO Info
in preparation
Languages

French

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.